Ting Li

发表

Breast cancer intrinsic subtype classification, clinical use and future trends.

Zhonghu Bai, Xiaofeng Dai, Xiaofeng Dai, 2015, American journal of cancer research.

Pathology-Confirmed Granuloma Mimicking Liver Metastasis of Breast Cancer

R. Shui, Ting Li, M. Fan, 2014, The International journal of biological markers.

Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial

S. Zhang, J. Ragaz, Si Sun, 2015, PloS one.

Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study

W. Yao, Ting Li, Jian Zhang, 2022, Frontiers in Oncology.

DNA damage response inhibitors: An avenue for TNBC treatment.

Ting Li, Xichun Hu, Jun Cao, 2021, Biochimica et biophysica acta. Reviews on cancer.

Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT

W. Ji, Ting Li, Xichun Hu, 2021 .

Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer.

Ting Li, Jian Zhang, Leiping Wang, 2021, Annals of palliative medicine.

Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia

Bao-ying Yuan, Ting Li, Yizi Jin, 2019, Breast Cancer Research and Treatment.

Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer

Ting Li, K. Lei, Yu-ming Jia, 2019, Medicine.

Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway.

Ting Li, Xichun Hu, Jiang Zhao, 2016, Biochemical and biophysical research communications.

Microwave Ablation Versus Nipple Sparing Mastectomy for Breast Cancer ≤5 cm: A Pilot Cohort Study

P. Liang, Xiaoling Yu, Zhi-yu Han, 2020, Frontiers in Oncology.

Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial

Ting Li, Jian Zhang, Leiping Wang, 2021, Investigational New Drugs.

Review Article Breast cancer intrinsic subtype classification, clinical use and future trends

Xiaofeng Dai, Xiuxia Liu, Yankun Yang, 2015 .

MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer

Ting Li, Xichun Hu, Z. Tao, 2016, Tumor Biology.

FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing SOD2 and IL6

Xiaofeng Dai, Hongye Cheng, Ting Li, 2019, International journal of biological sciences.

Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer

Ting Li, Jian Zhang, Leiping Wang, 2021, Cell Death & Disease.

Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway

Gong Yang, Z. Shao, Ting Li, 2014, BMC Cancer.

Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers

Ting Li, Jie Sun, Jianxia Liu, 2021, Frontiers in Oncology.

Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation

Ting Li, Jian Zhang, Leiping Wang, 2023, Cancer.

Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocrine Therapy and Subsequent Therapy: A Real-World Single-Center Retrospective Study in China

Ting Li, Jian Zhang, Leiping Wang, 2020, Medical science monitor : international medical journal of experimental and clinical research.

Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients

Ting Li, Jian Zhang, Leiping Wang, 2020, Frontiers in Oncology.

An integrated bioinformatics analysis to investigate the targets of miR-133a-1 in breast cancer

Ting Li, Jian Zhang, Leiping Wang, 2021, Translational cancer research.

Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases

Ting Li, Jian Zhang, Leiping Wang, 2021, BMC Cancer.

Comparison of 4th ESO-ESMO international consensus guidelines for advance breast cancer and Chinese anti-cancer association committee of Breast Cancer Society guideline.

Z. Shao, Ting Li, Jian Zhang, 2019, Breast.

A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer

S. Zhang, Ting Li, Jian Zhang, 2017, Oncotarget.

Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy

S. Zhang, Ting Li, M. Fan, 2015, Oncotarget.

Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer

Ting Li, Ming-chuan Zhao, Jian Zhang, 2023, Journal of Translational Medicine.

Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia

Bao-ying Yuan, Ting Li, Yizi Jin, 2020, Breast Cancer Research and Treatment.

Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT

W. Ji, Ting Li, Xichun Hu, 2022, Breast Cancer Research and Treatment.

Liposomal irinotecan (HR070803) in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors: a phase 1b dose-escalation and expansion study.

Ting Li, D. Ji, W. Shen, 2024, Investigational new drugs.